/ELV
ELV Stock - Elevance Health Inc.
Healthcare|Medical - Healthcare PlansNYSE
$340.69-1.13%
$3.91 (-1.13%) • Dec 19
68
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.47
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).75
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.99
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+12.6%upside
Target: $383.62
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for ELV
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$337.28 – $344.10
TARGET (TP)$383.67
STOP LOSS$313.43
RISK/REWARD1:1.6
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.53
52W High$458.75
52W Low$273.71
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $176.81B | $171.34B | $156.59B | $138.64B | $121.87B |
| Gross Profit | $176.81B | $171.34B | $156.59B | $138.64B | $121.87B |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating Income | $7.90B | $7.71B | $7.60B | $8.00B | $6.24B |
| Net Income | $5.98B | $5.99B | $5.89B | $6.16B | $4.57B |
| Net Margin | 3.4% | 3.5% | 3.8% | 4.4% | 3.8% |
| EPS | $25.81 | $25.38 | $24.56 | $25.25 | $18.23 |
Company Overview
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022. Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
5
42%
Hold / Neutral
7
58%
Sell / Underperform
0%
Analyst Consensus🔴 Bearish
5 Bullish7 Neutral/Bearish
Price Targets
$521
Average Target
↑ 53.1% Upside
Now
$310
Low
$521
Average
$649
High
Based on 14 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 19th 2025 | Deutsche Bank | Downgrade | Hold | $320 |
| October 14th 2025 | Goldman | Initiation | Neutral | - |
| July 21st 2025 | Argus | Downgrade | Hold | - |
| July 18th 2025 | Leerink Partners | Downgrade | Market Perform | $310 |
| April 15th 2025 | Robert W. Baird | Downgrade | Neutral | $529 |
| March 17th 2025 | Argus | Upgrade | Buy | $450 |
| January 22nd 2025 | Stephens | Downgrade | Equal Weight | $440← $520 |
| October 18th 2024 | Argus | Downgrade | Hold | - |
| July 18th 2024 | BofA Securities | Downgrade | Neutral | $530← $646 |
| June 24th 2024 | Morgan Stanley | Initiation | Overweight | $643 |
| May 30th 2024 | Robert W. Baird | Initiation | Outperform | $649 |
| March 6th 2024 | Barclays | Initiation | Overweight | $584 |
| July 12th 2023 | Wolfe Research | Downgrade | Peer Perform | - |
| April 27th 2023 | Morgan Stanley | Upgrade | Overweight | $571← $500 |
| April 21st 2023 | Cantor Fitzgerald | Initiation | Overweight | $547 |
Earnings History & Surprises
ELVBeat Rate
89%
Last 18 quarters
Avg Surprise
+3.5%
EPS vs Estimate
Beats / Misses
16/2
Last 12 quarters
Latest EPS
$6.03
Q4 2025
EPS Surprise History
Q1 24
+1.3%
$5.62vs$5.55
Q2 24
+1.0%
$10.64vs$10.53
Q3 24
+1.1%
$10.12vs$10.01
Q4 24
-13.4%
$8.37vs$9.66
Q1 25
+1.1%
$3.84vs$3.80
Q2 25
+4.9%
$11.97vs$11.41
Q3 25
-0.8%
$8.84vs$8.91
Q4 25
+22.3%
$6.03vs$4.93
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 20, 2026 | — | — | — | — |
Q1 2026 | Jan 22, 2026 | $3.19 | — | — | — |
Q4 2025 | Oct 21, 2025 | $4.93 | $6.03 | +22.3% | ✓ BEAT |
Q3 2025 | Jul 17, 2025 | $8.91 | $8.84 | -0.8% | ✗ MISS |
Q2 2025 | Apr 22, 2025 | $11.41 | $11.97 | +4.9% | ✓ BEAT |
Q1 2025 | Jan 23, 2025 | $3.80 | $3.84 | +1.1% | ✓ BEAT |
Q4 2024 | Oct 17, 2024 | $9.66 | $8.37 | -13.4% | ✗ MISS |
Q3 2024 | Jul 17, 2024 | $10.01 | $10.12 | +1.1% | ✓ BEAT |
Q2 2024 | Apr 18, 2024 | $10.53 | $10.64 | +1.0% | ✓ BEAT |
Q1 2024 | Jan 24, 2024 | $5.55 | $5.62 | +1.3% | ✓ BEAT |
Q4 2023 | Oct 18, 2023 | $8.45 | $8.99 | +6.4% | ✓ BEAT |
Q3 2023 | Jul 19, 2023 | $8.80 | $9.04 | +2.7% | ✓ BEAT |
Q2 2023 | Apr 19, 2023 | $9.26 | $9.46 | +2.2% | ✓ BEAT |
Q1 2023 | Jan 25, 2023 | $5.20 | $5.23 | +0.6% | ✓ BEAT |
Q4 2022 | Oct 19, 2022 | $7.15 | $7.53 | +5.3% | ✓ BEAT |
Q3 2022 | Jul 20, 2022 | $7.74 | $8.04 | +3.9% | ✓ BEAT |
Q2 2022 | Apr 20, 2022 | $7.81 | $8.25 | +5.6% | ✓ BEAT |
Q1 2022 | Jan 26, 2022 | $5.11 | $5.14 | +0.6% | ✓ BEAT |
Q4 2021 | Oct 20, 2021 | $6.37 | $6.79 | +6.6% | ✓ BEAT |
Q3 2021 | Jul 21, 2021 | $6.33 | $7.03 | +11.1% | ✓ BEAT |
Latest News
President Trump Says We Could Get Insurance Companies To Cut Prices To Stay In System; I Will Call Meeting Of Insurance Companies To Get Their Price Down; Meeting In Coming Weeks
📈 PositiveBenzinga•Dec 19, 2025, 08:03 PM•Also: , ,
Deutsche Bank Downgrades Elevance Health to Hold, Lowers Price Target to $320
📉 NegativeBenzinga•Dec 19, 2025, 05:29 PM•Also:
Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $352
➖ NeutralBenzinga•Dec 18, 2025, 05:48 PM
Shares of healthcare stocks are trading higher amid the Republican healthcare bill failing to win enough votes to advance in the Senate.
📈 PositiveBenzinga•Dec 11, 2025, 07:46 PM•Also: , ,
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $400
📈 PositiveBenzinga•Nov 26, 2025, 04:27 PM
Reuters: Some States Operating ACA Marketplaces Say Enrollment Is Significantly Down From Same Period Last Year, California Says ACA Enrollment Down By 33% vs Last Year
📉 NegativeBenzinga•Nov 24, 2025, 07:22 PM•Also: , ,
Politico Reported The White House To Propose A Two-year Extension Of Obamacare Subsidies With New Limits On Eligibility
➖ NeutralBenzinga•Nov 24, 2025, 11:16 AM•Also: , ,
Shares of health insurers are trading higher amid a possible rebound after President Trump recently proposed that healthcare funding should go directly to people. On Monday, the Senate passed its shutdown-ending bill that lacked a provision to extend Obamacare subsidies; however, the Democrats secured a commitment to vote on credits in December.
📈 PositiveBenzinga•Nov 12, 2025, 05:44 PM•Also: , ,
Elevance CFO Says Co Sees Medicaid Margin Declining At Least 125 BPs In 2026
📉 NegativeBenzinga•Nov 11, 2025, 08:07 PM
Elevance Health shares are trading higher after the company reaffirmed its 2025 guidance.
📈 PositiveBenzinga•Nov 11, 2025, 05:00 PM
Elevance Health Reaffirms 2025 Guidance: GAAP EPS ~$24.70, Adjusted EPS ~$30.00
📈 PositiveBenzinga•Nov 10, 2025, 10:18 PM
Shares of healthcare stocks are trading lower after the US Senate approved a deal clearing the path to ending the government shutdown. The deal does not include an extension of expiring Affordable Care Act subsidies
📉 NegativeBenzinga•Nov 10, 2025, 04:12 PM•Also: , ,
Mizuho Maintains Outperform on Elevance Health, Lowers Price Target to $400
➖ NeutralBenzinga•Nov 4, 2025, 11:49 AM
JP Morgan Maintains Overweight on Elevance Health, Raises Price Target to $394
📈 PositiveBenzinga•Oct 28, 2025, 12:49 PM
TD Cowen Maintains Buy on Elevance Health, Raises Price Target to $380
📈 PositiveBenzinga•Oct 23, 2025, 03:21 PM
Elevance Health shares are trading lower after multiple firms lowered their price targets on the stock.
📉 NegativeBenzinga•Oct 22, 2025, 01:49 PM
Wells Fargo Maintains Overweight on Elevance Health, Lowers Price Target to $403
➖ NeutralBenzinga•Oct 22, 2025, 01:28 PM
Barclays Maintains Overweight on Elevance Health, Lowers Price Target to $385
➖ NeutralBenzinga•Oct 22, 2025, 12:56 PM•Also:
Elevance Health Exec Says The Anticipated Expiration Of Enhanced Subsidies Would Significantly Impact Membership In 2026; Co Is Expanding Behavioral Health Interventions, Strengthening Specialty Drug Management; Co Is Planning For Higher Costs In Its Obamacare Plans In Q4 As Members Utilize Their Benefits Ahead Of Coverage Changes Next Year; Says 2026 Will Be The Low Point In Medicaid Margins, With Improvement Expected In 2027
📉 NegativeBenzinga•Oct 21, 2025, 01:32 PM
ELV stock has given up its prior gain. Elevance Health shares were trading higher after the company reported a Q3 earnings beat and raised FY2025 GAAP EPS guidance.
➖ NeutralBenzinga•Oct 21, 2025, 01:32 PM
Frequently Asked Questions about ELV
What is ELV's current stock price?
Elevance Health Inc. (ELV) is currently trading at $340.69 per share. The stock has moved -1.13% today.
What is the analyst price target for ELV?
The average analyst price target for ELV is $383.67, based on 1 analyst.
What sector is Elevance Health Inc. in?
Elevance Health Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Plans industry. The company is traded on the NYSE exchange.
What is ELV's market cap?
Elevance Health Inc. has a market capitalization of $75.71 billion, making it a large-cap company.
Does ELV pay dividends?
No, Elevance Health Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBDX
Becton, Dickinson and Company
$195.59
Mkt Cap: $56.3B
CI
Cigna Corporation
$271.89
Mkt Cap: $72.6B
COR
Cencora, Inc.
$340.93
Mkt Cap: $66.1B
CVS
CVS Health Corporation
$77.72
Mkt Cap: $98.7B
GEHC
GE HealthCare Technologies Inc.
$82.89
Mkt Cap: $37.9B
GSK
GSK plc
$48.61
Mkt Cap: $98.8B
HUM
Humana Inc.
$259.40
Mkt Cap: $31.2B
IDXX
IDEXX Laboratories, Inc.
$700.34
Mkt Cap: $55.9B
REGN
Regeneron Pharmaceuticals, Inc.
$767.96
Mkt Cap: $79.3B
ZTS
Zoetis Inc.
$122.24
Mkt Cap: $53.9B
Explore stocks similar to ELV for comparison